Our CEO spoke with @proactive_UK on the LOI signed with ILiAD Biotechologies for a pivotal phase 3 human challenge trial to assess their whooping cough #vaccine candidate:

🔬 World first pivotal Phase 3 Bordetella pertussis HCT
✅ Expanding hVIVO’s human challenge model portfolio
🦠 Whooping cough unmet medical need

Tune in here:#HVO #HCT #ChallengeTrials #Bacteria #Pertussis #WhoopingCough